Pliant Therapeutics: Targeting Idiopathic Pulmonary Fibrosis (NASDAQ:PLRX)
designer491/iStock via Getty Images Peace is not absence of conflict, it is the ability to handle conflict by peaceful means.” – Brian Tracy. Today, we put Pliant Therapeutics, Inc. (NASDAQ:PLRX) in the spotlight. The company’s lead asset seems to have significant promise and is targeting a couple of potentially lucrative indications. Analyst firms are quite…